User profiles for Renato V. LaRocca

Renato V. La Rocca

Kentucky Cancer Group
Verified email at kci.us
Cited by 6669

Characteristics of cell lines established from human gastric carcinoma

JG Park, H Frucht, RV LaRocca, DP Bliss Jr, Y Kurita… - Cancer research, 1990 - AACR
We report the establishment and characterization of four continuous cell lines derived from
human primary and metastatic gastric carcinomas, and we compare their properties with a …

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis

…, GP Chrousos, MF Brennan, CA Stein, RV La Rocca - Cancer research, 1990 - AACR
We established a continuous cell line, NCI-H295, from an invasive primary adrenocortical
carcinoma. The cell line was established in a fully defined medium (HITES) and later could be …

[PDF][PDF] Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for …

…, S Ramalingam, MC Perry, RV LaRocca… - Journal of Clinical …, 2008 - academia.edu
Purpose To compare the efficacy and safety of weekly paclitaxel in combination with
carboplatin administered every 4 weeks to the standard regimen of paclitaxel and carboplatin …

Validity of self-reported smoking status among participants in a lung cancer screening trial

…, AS LaJoie, MA Andrykowski, RV LaRocca - … Biomarkers & Prevention, 2006 - AACR
Lung cancer remains a devastating disease associated with substantial morbidity and
mortality. Recent research has suggested that lung cancer screening with spiral computed …

[HTML][HTML] Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: Safety and efficacy assessment

…, DE Piccioni, CM Duma, RV LaRocca… - Journal of Experimental …, 2022 - Springer
Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A
multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the …

Multicenter, randomized trial for stage IIIB or IV non–small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or …

CP Belani, J Barstis, MC Perry, RV La Rocca… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To explore the efficacy and safety of three regimens of weekly paclitaxel plus
carboplatin as initial therapy and the feasibility of subsequent maintenance therapy versus …

Cancer susceptibility variants and the risk of adult glioma in a US case–control study

…, LB Nabors, JJ Olson, DJ Brat, RV LaRocca… - Journal of neuro …, 2011 - Springer
Malignant gliomas are the most common and deadly brain tumors. Although their etiology
remains elusive, recent studies have narrowed the search for genetic loci that influence risk. …

Reproductive factors and risk of primary brain tumors in women

…, MH Madden, LB Nabors, JJ Olson, RV LaRocca… - Journal of neuro …, 2014 - Springer
Gender-specific incidence patterns and the presence of hormonal receptors on tumor cells
suggest that sex hormones may play a role in the onset of primary brain tumors. However, …

[HTML][HTML] Prevention and management of dermatologic adverse events associated with tumor treating fields in patients with glioblastoma

…, F Iwamoto, SA Jeyapalan, RV La Rocca… - Frontiers in …, 2020 - frontiersin.org
Importance: Tumor Treating Fields (TTFields) are an antineoplastic treatment approved for
treating newly diagnosed and recurrent glioblastoma, and mesothelioma. TTFields in …

Anthropometric factors in relation to risk of glioma

…, RC Thompson, JJ Olson, RV LaRocca… - Cancer Causes & …, 2013 - Springer
Introduction Increased height and greater adiposity have been linked to an increased risk of
many cancer types, though few large studies have examined these associations in glioma. …